Thomas I H Dubin's Net Worth

$55.2 Million

Estimate Recalculated Sep 8, 2024 07:31PM EST

Who is Thomas I H Dubin?

Thomas I H Dubin has an estimated net worth of $55.2 Million. This is based on reported shares across multiple companies, which include Notable Labs, Ltd., ALEXION PHARMACEUTICALS INC, and INTENSITY THERAPEUTICS, INC..

SEC CIK

Thomas I H Dubin's CIK is 0001231945

Past Insider Trading and Trends

2012 was Thomas I H Dubin's most active year for acquiring shares with 20 total transactions. Thomas I H Dubin's most active month to acquire stocks was the month of December. 2007 was Thomas I H Dubin's most active year for disposing of shares, totalling 59 transactions. Thomas I H Dubin's most active month to dispose stocks was the month of October. 2012 saw Thomas I H Dubin paying a total of $7,792,802.59 for 565,623 shares, this is the most they've acquired in one year. In 2012 Thomas I H Dubin cashed out on 1,004,532 shares for a total of $49,201,377.87, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Notable Labs, Ltd. (NTBL) Snapshot price: $0.4921

Investor

Thomas I H Dubin owns 40,247 units of Ordinary Shares which is worth $19,805.55. In the year 2024 Thomas I H Dubin filed a total of 3 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
40.25K
—
—
40.25K
May 8
Form 4
—
0
—
—
0
Jan 24
Form 3
—
0
—
—
0
No matching records found

ALEXION PHARMACEUTICALS INC No price found

SVP & Chief Legal Officer

Thomas I H Dubin owns 21,512 units of Common Stock, par value $.0001, 65,705 units of Common Stock, par value $.0001 per share and 151,894 units of Common Stock, par value $.001 per share. In the year 2005 Thomas I H Dubin acquired a total of 817,135 shares in ALEXION PHARMACEUTICALS INC at a cost of $10,828,195.04, Thomas also disposed a total of 784,526 shares of ALEXION PHARMACEUTICALS INC equalling to $66,049,064.38.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-33.79%
-33.53K
$103.30
-$3,463,577.52
65.7K
Scheduled
Aug 23
Form 4
-1.34%
-1.35K
$66.56
-$14,336,251.31
99.23K
Jul 27 - Jul 31
Form 4
—
0
$55.84
-$3,247,677.32
100.58K
Jun 15
Form 4
—
0
$52.89
-$8,091,606.65
100.58K
May 29
Form 4
+28.91%
38.69K
$10.43
$406,011.80
172.51K
May 10 - May 14
Form 4
—
0
$48.67
-$5,302,896.48
263.19K
Mar 14
Form 4
-5.08%
-17.87K
$44.31
-$7,131,924.95
333.81K
Feb 22
Form 4
+11.13%
8K
—
—
79.89K
Feb 3
Form 4
-3.57%
-2.67K
$74.49
-$198,502.85
71.89K
Jan 27 - Jan 30
Form 4
-0.75%
-562.00
$75.00
-$42,150.00
74.56K
Jan 10
Form 4
—
0
$37.61
-$2,500,644.80
75.12K
Oct 24
Form 4
+80.61%
33.53K
$5.21
$174,539.44
75.12K
Aug 22
Form 4
-1.58%
-669.00
$31.24
-$1,754,142.03
41.59K
Jul 25 - Jul 27
Form 4
-1.17%
-501.00
$50.00
-$25,050.00
42.26K
Jul 11
Form 4
-16.61%
-4.31K
$99.27
-$427,853.70
21.63K
Mar 2
Form 4
+23.88%
5K
—
—
25.94K
Feb 2
Form 4
-5.94%
-1.32K
$84.70
-$112,058.10
20.94K
Jan 27
Form 4
-1.18%
-265.00
$82.66
-$21,904.90
22.27K
Jan 18
Form 4
-1.23%
-280.00
$81.27
-$22,755.60
22.53K
Jan 10
Form 4
—
0
$46.45
-$2,875,791.95
22.81K
Scheduled
Nov 29
Form 4
—
0
$42.74
-$1,002,572.90
22.81K
Oct 26
Form 4
—
0
$37.92
-$809,000.00
9.93K
Sep 3
Form 4
-2.45%
-249.00
$51.08
-$12,718.92
9.93K
Jul 16
Form 4
-2.39%
-249.00
$51.91
-$12,925.59
10.18K
Jul 12
Form 4
+135.38%
6K
—
—
10.43K
Jan 28
Form 4
-5.32%
-249.00
$47.22
-$11,757.78
4.43K
Jan 19
Form 4
-22.79%
-1.38K
$47.68
-$65,893.76
4.68K
Jan 11
Form 4
-49.96%
-6.05K
$26.63
-$1,935,486.00
6.06K
Jul 27
Form 4
-1.93%
-238.00
$38.96
-$9,272.48
12.12K
Jul 16
Form 4
-1.89%
-238.00
$36.93
-$8,789.34
12.36K
Jul 10
Form 4
-44.26%
-10.00K
$37.43
-$374,300.00
12.59K
Jun 4
Form 4
-8.99%
-2.23K
$34.25
-$76,446.00
22.59K
Mar 16
Form 4
-3.99%
-1.03K
$32.34
-$33,342.54
24.82K
Mar 10
Form 4
+44.80%
8K
—
—
25.86K
Jan 26
Form 4
-5.55%
-1.05K
$36.93
-$38,739.57
17.86K
Jan 16
Form 4
-1.47%
-282.00
$34.48
-$9,723.36
18.91K
Jan 12
Form 4
-5.10%
-1.03K
$40.12
-$41,363.72
19.19K
Sep 11
Form 4
-32.13%
-4.79K
$90.47
-$427,108.87
10.11K
Aug 8
Form 4
-0.80%
-120.00
$75.75
-$9,090.00
14.89K
Jul 10
Form 4
-3.32%
-515.00
$56.05
-$28,865.75
15.02K
Mar 10
Form 4
+18.69%
2.44K
$69.02
-$38,306.10
15.53K
Jan 9 - Jan 10
Form 4
-11.20%
-1.65K
$75.20
-$124,075.50
13.09K
Nov 29
Form 4
-31.46%
-6.76K
$74.43
-$503,290.28
14.73K
Nov 28
Form 4
+45.89%
6.76K
$44.15
-$696,538.37
21.5K
Nov 28
Form 4
-1.77%
-265.00
—
—
14.73K
Nov 2
Form 4
-3.31%
-514.00
$65.31
-$33,569.34
15K
Scheduled
Sep 10
Form 4
—
0
—
—
0
Jul 11
Form 4
-4.66%
-758.00
$37.15
-$28,159.70
15.51K
Scheduled
Mar 12
Form 4
+17.00%
3K
—
—
20.65K
Jan 15
Form 4
-1.94%
-350.00
$34.54
-$12,089.00
17.65K
Aug 18
Form 4
—
0
—
—
0
Jun 7
Form 4
+19.51%
3.51K
—
—
21.51K
Apr 7
Form 4
+20.00%
3K
$20.72
$62,160.00
18K
Jan 9
Form 4
—
0
—
—
0
Sep 21
Form 4/A
+650.00%
13K
—
—
15K
Mar 9
Form 4
+150.00%
3K
—
—
5K
Mar 9
Form 4
∞
2K
$17.32
$34,632.45
2K
Oct 12 - Oct 15
Form 4
—
0
—
—
0
Feb 24
Form 4
—
0
—
—
0
Sep 23
No matching records found

INTENSITY THERAPEUTICS, INC. (INTS) Snapshot price: $4.61

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 14
Form 3
—
0
—
—
0
No matching records found